Geron | GERN - Чистый доход





Чистый доход Изменить Дата
Amgen USD 1.82B 486M 2026-03
Bio Techne USD 51.05M 13.04M 2026-03
Cassava Sciences USD -12.54M 1.73M 2025-12
Cytokinetics USD -206.03M 23M 2026-03
Esperion Therapeutics USD 61.83M 93.16M 2025-12
Exelixis USD 210.47M 34.06M 2026-03
Genmab DKK 31M 370M 2025-12
Geron USD -3.64M 27.5M 2026-03
Gilead Sciences USD 2.02B 162M 2026-03
Incyte USD 303.33M 4.05M 2026-03
MacroGenics USD -14.16M 30.98M 2025-12
Novartis USD 3.16B 747M 2026-03
Novavax USD 17.53M 219.91M 2025-12